TrialRheumatology (Oxford, England)2020

Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR).

Ana-Maria Orbai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.